|
|
 |
MAGNEVIST® | | | General Information | |
| Vendor | | Berlex Inc. | | Item | | MAGNEVIST® | | Approval | | FDA | | Product Number | | 50419-188-1050419-188-0550419-188-30 | | Contrast For | | MRI | | Unit | | Box of 1, 5 or 20 | | Container | | 5 mL - 20 mL single dose vials 100 mL pharmacy bulk package | | Dosage | | 0.2 mL/kg (0.1 mmol/kg) | | Injection Rate | | 10 mL/15 sec | | Pricing |  | Inquire | | Financing | | To finance this purchase click here (U.S. customers only) |
| | Product Description | |
| When MAGNEVIST® (gadopentetate dimeglumine) injection was introduced in 1988, it ushered in the revolutionary concept of contrast-enhanced magnetic resonance imaging (MRI). It became the world's first contrast agent for use in MRI. Today, the product is still a market leader with indications in CNS, head, neck and body. MAGNEVIST® is used in over 85 countries and has established a positive clinical experience in more than 30 million patients worldwide. Clinical studies are also being pursued in vasculature and cardiac imaging. | |
| Berlex Inc. | | Customer Service: (510) 262-5000 | | Web site: http://www.berlex.com | | Please mention Medcompare.com when you contact the vendor. |
| NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary. |
|
|
